pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,050 catalysts · 4,779 phase readout · 2,339 8k filing · 286 earnings · 271 pdufa · 166 phase 2 completion · 71 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-20: 0 catalysts2026-07-21: 0 catalysts2026-07-22: 0 catalysts2026-07-23: 0 catalysts2026-07-24: 1 catalyst2026-07-25: 0 catalysts2026-07-26: 0 catalysts2026-07-27: 2 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: phase readout×type: pdufa×type: recall×clear all
type
  • phase readout4,779
  • 8k filing2,339
  • earnings286
  • pdufa271
  • phase 2 completion166
  • phase 1 completion71
phase 2 initiation
54
  • phase 1 initiation39
  • phase 1 2 completion33
  • phase 0 trial completion23
  • therapy area
    • Dermatology1
    • Infectious Disease1

    Date TBD

    50
    ›RECRUITINGphase readoutNCT06242327: An Outcome Analysis of Primary Membranous Nephropathy

    Sponsor: Mario Negri Institute for Pharmacological Research. Phase: . Conditions: Membranous Nephropathy

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07381127: INTUPRO in the Treatment of Benign Prostatic Hyperplasia-Related Symptoms

    Sponsor: inTumo Therapeutics, Inc.. Phase: NA. Conditions: BPH (Benign Prostatic Hyperplasia), BPH, BPH With Other Lower Urinary Tract Symptoms

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04436042: MyHand 2: An Active Hand Orthosis for Stroke Patients

    Sponsor: Columbia University. Phase: NA. Conditions: Stroke, Hemiparesis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04887142: Predictors of Disease Severity in COVID-19 Patients

    Sponsor: Zeljko Mijailovic. Phase: . Conditions: COVID-19

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06111586: FrexalimAB in Preservation of Endogenous insULIN Secretion Compared to Placebo in adUlts and Adolescents on Top of inSulin Therapy (FABULINUS)

    Sponsor: Sanofi. Phase: PHASE2. Conditions: Type 1 Diabetes Mellitus

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT06481670: Carbohydrate Fluids and Post Operative Nausea and Vomiting

    Sponsor: Boston Medical Center. Phase: NA. Conditions: Nausea, Postoperative, Vomiting, Postoperative

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06560970: A Technology-based Psychosocial Intervention to Support Social Engagement and Well-being in Older Adults With HIV

    Sponsor: Weill Medical College of Cornell University. Phase: NA. Conditions: HIV Diagnosis

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07521670: Sacituzumab Tirumotecan in Recurrent/Metastatic Adenoid Cystic Carcinoma and Papillary Thyroid Carcinoma (STRAP)

    Sponsor: National Cancer Centre, Singapore. Phase: PHASE2. Conditions: Recurrent Adenoid Cystic Carcinoma, Adenoid Cystic Carcinoma Metastatic, Papillary Thyroid Carcinoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07590973: Online Evaluation of the Diagnostic Accuracy of BlinkLab's Digital Assessments for Autism

    Sponsor: Blinklab Limited. Phase: . Conditions: Autism, Autism Spectrum Disorder, Autism Spectrum Disorder (ASD), Neurodevelopmental Conditions

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04241341: Does Immediate Lymphatic Reconstruction Decrease the Risk of Lymphedema After Axillary Lymph Node Dissection

    Sponsor: Memorial Sloan Kettering Cancer Center. Phase: PHASE3. Conditions: Breast Cancer Lymphedema

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06290505: A Trial of Palliative Chemotherapy, Radiation and Immune Treatment for Oesophageal Cancer: PALEO Study

    Sponsor: Australasian Gastro-Intestinal Trials Group. Phase: PHASE2. Conditions: Esophageal Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05354622: Hereditary Spastic Paraplegia Genomic Sequencing Initiative (HSPseq)

    Sponsor: Boston Children's Hospital. Phase: . Conditions: Hereditary Spastic Paraplegia, Neurodegenerative Diseases, Pediatric Disorder, Spasticity, Muscle, Motor Neuron Disease, Movement Disorders

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07246629: Lumbar Drain With Intrathecal Nicardipine in Aneurysmal Subarachnoid Hemorrhage

    Sponsor: Wake Forest University Health Sciences. Phase: PHASE4. Conditions: Subarachnoid Hemorrhage

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT02993029: 99Tc-MDP Treatment for Knee Osteoarthritis

    Sponsor: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine. Phase: NA. Conditions: Treatment Outcome

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT01628029: Cognitive Behavioral Therapy and Multimodal Therapy in Treating Sleep Disturbance in Patients With Cancer

    Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm, Sleep Disorder

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07539831: Effects of Menstrual Cycle on Optic Nerve Sheath Diameter in Patients Undergoing Laparoscopic Gynecologic Surgery

    Sponsor: Konya City Hospital. Phase: . Conditions: Menstrual Cycle, Optic Nerve Sheath Diameter, Postoperative Nausea and Vomiting

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT02936791: Early PKD Observational Cohort Study

    Sponsor: University of Kansas Medical Center. Phase: . Conditions: Polycystic Kidney Disease

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06212791: EXercise Cardiac Magnetic Resonance Assessment of Left Atrial Mechanics Following Ablation

    Sponsor: Virginia Commonwealth University. Phase: . Conditions: Paroxysmal Atrial Fibrillation

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06540118: Food Is Medicine for Patients With Heart Failure

    Sponsor: University of California, San Diego. Phase: NA. Conditions: Heart Failure, Heart Failure,Congestive, Heart Diseases

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07310290: Study to Assess the Real-World Effectiveness of Ubrogepant in Adult Participants When Treating During the Prodrome Phase of Migraine Attacks

    Sponsor: AbbVie. Phase: . Conditions: Migraine

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07133490: INTERACT Stomach-II

    Sponsor: Erasmus Medical Center. Phase: PHASE2. Conditions: Peritoneal Metastases From Gastric Cancer

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT02693990: A Trial of Increased Dose Intensity Modulated Proton Therapy (IMPT) for High-Grade Meningiomas

    Sponsor: Massachusetts General Hospital. Phase: NA. Conditions: Meningioma, Brain Tumor

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07115160: The Leksand Hockey Trial on Grip Strength

    Sponsor: Dalarna County Council, Sweden. Phase: NA. Conditions: Grip Strength, Performance, Injuries

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT06218082: Vitiligo Registry for Adults and Children in the UK

    Sponsor: The Royal Wolverhampton Hospitals NHS Trust. Phase: . Conditions: Dermatologic Disease, Vitiligo

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06041282: Conservative Treatment of Early Adhesive Capsulitis

    Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University. Phase: NA. Conditions: Adhesive Capsulitis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07408024: Safety and Efficacy of TollB-001 Tablets in Moderate to Severe Rheumatoid Arthritis

    Sponsor: Toll Biotech Co. Ltd. (Beijing). Phase: PHASE2. Conditions: Rheumatoid Arthritis (RA)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07602023: Triglyceride-rich LIPoproteins and INflammatory Cytokines After Oral FAT Loading as Potential Early Biomarkers of the Risk of Progression Towards DIABETES and Development of Complications. LIPINFAT Diabetes Study.

    Sponsor: Angelina Passaro. Phase: . Conditions: Prediabetes / Type 2 Diabetes

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04393623: Stress, Emotion Regulation, and Alcohol in Women Veterans

    Sponsor: VA Office of Research and Development. Phase: NA. Conditions: Alcohol Use Disorder, Post Traumatic Stress Disorder

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07589023: A Retrospective Review: Outcomes of the REFLECT™ System for Idiopathic Scoliosis

    Sponsor: Globus Medical Inc. Phase: . Conditions: Idiopathic Scoliosis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04569123: Concomitant Sensory Stimulation During Therapy to Enhance Hand Functional Recovery Post Stroke

    Sponsor: Medical University of South Carolina. Phase: NA. Conditions: Stroke, Physical Disability

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07482059: A Multicenter Clinical Study of Combined Therapy for Unresectable Hepatocellular Carcinoma

    Sponsor: West China Hospital. Phase: PHASE1. Conditions: Unresectable Hepatocellular Carcinoma

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07524296: QTc Interval in Cesarean Section Patients

    Sponsor: Haseki Training and Research Hospital. Phase: NA. Conditions: Pregnant Women, Cesarean Birth

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07498062: Multimodal Chewing Gum Flavour Training to Aid Flavour Perception Recovery - a Pilot Study.

    Sponsor: University of Nottingham. Phase: NA. Conditions: Anosmia, Parosmia, Phantosmia, Dysgeusia, Ageusia

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07262788: A Feasibility Study of Optimal Non-Pharmacological Lifestyle Modifications in People With Type 2 Diabetes

    Sponsor: Steno Diabetes Center Copenhagen. Phase: NA. Conditions: Type 2 Diabetes

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07491003: Laparoscopic Hiatal Hernia Repair With Mesh Cruroplasty

    Sponsor: Zagazig University. Phase: NA. Conditions: Hiatal Hernia, Sleeve Gastrectomy

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06854627: Effect of Continuous Prolonged Prone Position Versus Intermittent Daily Prone Position in ARDS

    Sponsor: Pontificia Universidad Catolica de Chile. Phase: NA. Conditions: Acute Respiratory Distress Syndrome

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07076342: The Role of mGluR5 in CBT-I

    Sponsor: Stony Brook University. Phase: PHASE4. Conditions: Major Depressive Disorder (MDD)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06693986: Adenovirus (RGDCRAdCOX2F)

    Sponsor: Masonic Cancer Center, University of Minnesota. Phase: PHASE1. Conditions: Adenocarcinoma of Pancreas

    full page →ctgov ↗
    ›AVAILABLEphase readoutNCT03773770: Expanded Access to Triheptanoin

    Sponsor: Ultragenyx Pharmaceutical Inc. Phase: . Conditions: Long Chain Fatty Acid Oxidation Disorders

    full page →ctgov ↗
    ›WITHDRAWNphase readoutNCT06648473: Repeatability of Magnetic Resonance Imaging in Patients With IDH1 Mutant Glioma on Ivosidenib

    Sponsor: Duke University. Phase: NA. Conditions: Low Grade Glioma of Brain

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07251673: Longitudinal Study of Phenotypic and Developmental Severity in Patients With Dravet Syndrome With SCN1A Gene Mutation

    Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: . Conditions: Dravet Syndrome

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06854367: Accelerated vs. Conventional Theta Burst Stimulation for Late-life Depression

    Sponsor: Centre for Addiction and Mental Health. Phase: NA. Conditions: Late Life Depression (LLD), Depression - Major Depressive Disorder, Depressive Disorder, Treatment-Resistant, Mood Disorders

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT03796767: Salvage Oligometastasectomy and Radiation Therapy in Recurrent Prostate Cancer

    Sponsor: University of Utah. Phase: PHASE2. Conditions: Recurrent Prostate Carcinoma, Metastatic Malignant Neoplasm in the Bone, Metastatic Malignant Neoplasm in the Lymph Nodes, Oligometastasis, Prostate Adenocarcinoma, PSA Failure

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT00086567: Predictors of Relapse of Ovarian, Peritoneal, and Fallopian Tube Cancers

    Sponsor: National Cancer Institute (NCI). Phase: . Conditions: Fallopian Tube Cancer, Peritoneal Neoplasms, Epithelial Ovarian Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07179107: Adequate Hydration and Health Outcomes

    Sponsor: Arizona State University. Phase: NA. Conditions: Dehydration, Dehydration (Physiology), Glucose Abnormalities, Cardiovascular

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07327307: Real World Evidence Study of SYN023 in Children Exposed to Rabies

    Sponsor: Synermore Biologics (Suzhou) Co., Ltd.. Phase: . Conditions: Rabies Post-exposure Prophylaxis

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07609511: Magnet System Gastric Outlet Obstruction Study

    Sponsor: GT Metabolic Solutions, Inc.. Phase: NA. Conditions: Gastric Outlet Obstruction

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06505811: Mixed Methods Evaluation of the Pomona Household Universal Grant (HUG) Program

    Sponsor: University of California, Los Angeles. Phase: NA. Conditions: Early Child Well-being, Parental Stress, Family Economic Security, Parental/Caregiver Health, Mental Health

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07407465: Upfront Trastuzumab-Deruxtecan Plus Capecitabine and Bevacizumab for Patients With HER-2 Positive Metastatic Colorectal Cancer.

    Sponsor: Gruppo Oncologico del Nord-Ovest. Phase: PHASE2. Conditions: Colorectal Cancer, Colorectal Adenocarcinoma, Rectal Adenocarcinoma, Rectal Cancer, Adenocarcinoma, Rectal Cancer, Metastatic, Colon Cancer Metastatic, Colon Cancer Adenocarcinoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06532565: Study of GS-2121 Given Alone or in Combination in Adults With Advanced Solid Tumors

    Sponsor: Gilead Sciences. Phase: PHASE1. Conditions: Advanced Solid Tumors

    full page →ctgov ↗
    ← prev
    page 53 of 101
    next →